Related Experiment Video
Updated: Feb 20, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
8.9K
Development and Validation of Cardiology-Specific Quality Indicators for Clinical Pharmacists: A Modified Delphi
Asma M Alshahrani1, Mohammed Ahmed Alishaq2, Manea Fares Al Munjem2
1Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Dawadimi, Saudi Arabia.
International Journal of General Medicine
|February 19, 2026
Summary
Researchers developed 23 quality indicators for drug therapy problems (QI-DTPs) in cardiology, achieving strong consensus among Saudi Arabian clinical pharmacists. These indicators aim to improve cardiovascular care and medication safety.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Healthcare Quality Improvement
Background:
- Clinical pharmacists are crucial in cardiology for optimizing drug therapy and patient outcomes.
- A lack of standardized quality indicators hinders the evaluation of clinical pharmacists' impact in cardiology.
- This gap necessitates the development of specific metrics to assess and improve cardiovascular pharmacotherapy.
Purpose of the Study:
- To develop and validate cardiology-specific Quality Indicator Drug Therapy Problems (QI-DTPs).
- To establish medication-related quality indicators for identifying, preventing, and resolving drug therapy problems in cardiovascular care.
- To achieve consensus on these indicators using a modified Delphi technique in Saudi Arabia.
Main Methods:
- A comprehensive literature review and expert group consultation generated 23 candidate QI-DTPs.
- A modified Delphi approach involving 16 expert clinical pharmacists in Saudi Arabia was employed.
- Indicators were rated on a 9-point Likert scale, with ≥75% consensus required for validation over three rounds.
Main Results:
- Sixteen expert clinical pharmacists, with extensive cardiology experience, participated in the study.
- All 23 proposed QI-DTPs achieved the ≥75% consensus threshold.
- Strong agreement was demonstrated regarding the relevance, clarity, and applicability of the validated QI-DTPs.
Conclusions:
- The study successfully validated 23 QI-DTPs through strong consensus among Saudi Arabian clinical pharmacists.
- Implementing these QI-DTPs can enhance cardiovascular care quality, support pharmacist interventions, and improve medication safety.
- Future research should focus on evaluating the impact of these quality metrics on patient outcomes.
Keywords:
Delphi methodcardiologyclinical pharmacydrug therapy problemsmedication optimizationpharmacist led interventionsquality indicator–drug therapy problemsMore Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
6.0K
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
3.5K
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
01:27Peripheral Artery Disease III: Interprofessional Care
385
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
385
01:27Coronary Artery Disease V: Interprofessional Care
315
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
315
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
622
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
238
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
238